Prediction Of Serious Adverse Event in Emergency Department With dysKAlemia, Retrospective Study
PODKA-R
1 other identifier
observational
500
1 country
1
Brief Summary
Dyskalemia, hypo- and hyperkalemia are common in the emergency department and are associated with increased morbidity and mortality. The potential seriousness of dyskalemia results from the potential alteration of intracardiac conduction and the increase in cardiac rhythm disorders, all associated with a lethal risk. Given the aspecific symptoms of dyskalemia and the complex causal links to be acquired, it is difficult to judge the severity of the disorders in front of an initial clinical presentation of a patient in the emergency room, as the patient may present a serious condition during his stay in the emergency room, related to the dyskalemia and not prejudged at first. The ECG is recommended to judge the severity of the disorder, in association with the level of kalemia, but the electrical changes of its pattern in the context of dyskalemia are sometimes so fine that even the eye of the practitioner is not able to detect them. To date and to our knowledge, there is no tool for predicting the risk of RTA or death in dyskalemia. The existing studies on the subject, including ECGs, seek to detect dyskalemia and not its complications, and the proposed tools only take into account the ECG and not the clinical context of the patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2023
CompletedFirst Submitted
Initial submission to the registry
March 15, 2023
CompletedFirst Posted
Study publicly available on registry
March 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedApril 27, 2025
February 1, 2025
12 months
March 15, 2023
April 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with Cardiac arrest and/or rhythm disorder
Number of patients with Cardiac arrest and/or rhythm disorder within 48 hours of the ED visit
within 48 hours
Secondary Outcomes (2)
Rate of Mortality
within 48 hours
The type of received treatment for dyskalemia
within 48 hours
Eligibility Criteria
patients consulted in the emergency unit of the participating centre, with quality criteria for the EHCs; this cohort will validate the Artificial Intelligence method developed in partnership with the laboratory
You may qualify if:
- Major patient consulting in an emergency department participating in the study
- who received at least a digital ECG AND an ionogram in the emergency department during the study period
You may not qualify if:
- Patient who has expressed opposition to the reuse of their data for the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHR Metz-Thionville/Hopital de Mercy
Metz, 57085, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laure ABENSUR VUILLAUME, MD, PhD
CHR Metz Thionville Hopital de Mercy
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2023
First Posted
March 29, 2023
Study Start
January 2, 2023
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
April 27, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share